nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfanilamide—CYP2C19—epilepsy syndrome	0.141	0.574	CbGaD
Sulfanilamide—CYP2D6—epilepsy syndrome	0.105	0.426	CbGaD
Sulfanilamide—CA6—Lacosamide—epilepsy syndrome	0.0463	0.0696	CbGbCtD
Sulfanilamide—CA9—Lacosamide—epilepsy syndrome	0.0346	0.0521	CbGbCtD
Sulfanilamide—CA6—Acetazolamide—epilepsy syndrome	0.0318	0.0479	CbGbCtD
Sulfanilamide—CA6—Zonisamide—epilepsy syndrome	0.0295	0.0443	CbGbCtD
Sulfanilamide—CA2—Lacosamide—epilepsy syndrome	0.028	0.0421	CbGbCtD
Sulfanilamide—CA7—Acetazolamide—epilepsy syndrome	0.0277	0.0418	CbGbCtD
Sulfanilamide—CA7—Zonisamide—epilepsy syndrome	0.0257	0.0386	CbGbCtD
Sulfanilamide—CA12—Acetazolamide—epilepsy syndrome	0.0238	0.0358	CbGbCtD
Sulfanilamide—CA9—Acetazolamide—epilepsy syndrome	0.0238	0.0358	CbGbCtD
Sulfanilamide—CA9—Zonisamide—epilepsy syndrome	0.022	0.0332	CbGbCtD
Sulfanilamide—CA12—Zonisamide—epilepsy syndrome	0.022	0.0332	CbGbCtD
Sulfanilamide—CA6—Topiramate—epilepsy syndrome	0.0215	0.0323	CbGbCtD
Sulfanilamide—CA2—Acetazolamide—epilepsy syndrome	0.0193	0.029	CbGbCtD
Sulfanilamide—CA7—Topiramate—epilepsy syndrome	0.0187	0.0282	CbGbCtD
Sulfanilamide—CA2—Zonisamide—epilepsy syndrome	0.0178	0.0268	CbGbCtD
Sulfanilamide—CA12—Topiramate—epilepsy syndrome	0.0161	0.0242	CbGbCtD
Sulfanilamide—CA9—Topiramate—epilepsy syndrome	0.0161	0.0242	CbGbCtD
Sulfanilamide—CA2—Topiramate—epilepsy syndrome	0.013	0.0195	CbGbCtD
Sulfanilamide—CYP2E1—Felbamate—epilepsy syndrome	0.0121	0.0182	CbGbCtD
Sulfanilamide—CYP2E1—Trimethadione—epilepsy syndrome	0.0121	0.0182	CbGbCtD
Sulfanilamide—CYP2E1—Clonazepam—epilepsy syndrome	0.0103	0.0155	CbGbCtD
Sulfanilamide—CYP2E1—Rufinamide—epilepsy syndrome	0.00838	0.0126	CbGbCtD
Sulfanilamide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00815	0.0123	CbGbCtD
Sulfanilamide—CYP2C19—Felbamate—epilepsy syndrome	0.00757	0.0114	CbGbCtD
Sulfanilamide—CYP2C19—Trimethadione—epilepsy syndrome	0.00757	0.0114	CbGbCtD
Sulfanilamide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00712	0.0107	CbGbCtD
Sulfanilamide—CYP2E1—Propofol—epilepsy syndrome	0.00683	0.0103	CbGbCtD
Sulfanilamide—CYP2E1—Phenobarbital—epilepsy syndrome	0.00653	0.00982	CbGbCtD
Sulfanilamide—CYP2E1—Midazolam—epilepsy syndrome	0.00643	0.00969	CbGbCtD
Sulfanilamide—CYP2C9—Trimethadione—epilepsy syndrome	0.0063	0.00948	CbGbCtD
Sulfanilamide—CYP2E1—Diazepam—epilepsy syndrome	0.00619	0.00931	CbGbCtD
Sulfanilamide—CYP2C19—Clobazam—epilepsy syndrome	0.00617	0.00929	CbGbCtD
Sulfanilamide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00592	0.00891	CbGbCtD
Sulfanilamide—CYP2C19—Carbamazepine—epilepsy syndrome	0.00512	0.0077	CbGbCtD
Sulfanilamide—CYP2C19—Primidone—epilepsy syndrome	0.00478	0.00719	CbGbCtD
Sulfanilamide—CYP2C19—Phenytoin—epilepsy syndrome	0.00459	0.00691	CbGbCtD
Sulfanilamide—CYP2C19—Propofol—epilepsy syndrome	0.00428	0.00644	CbGbCtD
Sulfanilamide—CYP2C9—Carbamazepine—epilepsy syndrome	0.00425	0.0064	CbGbCtD
Sulfanilamide—CYP2C19—Phenobarbital—epilepsy syndrome	0.00409	0.00616	CbGbCtD
Sulfanilamide—CYP2C9—Primidone—epilepsy syndrome	0.00397	0.00598	CbGbCtD
Sulfanilamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00394	0.00593	CbGbCtD
Sulfanilamide—CYP2C19—Diazepam—epilepsy syndrome	0.00388	0.00584	CbGbCtD
Sulfanilamide—CYP2C9—Phenytoin—epilepsy syndrome	0.00382	0.00574	CbGbCtD
Sulfanilamide—CYP2C19—Zonisamide—epilepsy syndrome	0.00378	0.0057	CbGbCtD
Sulfanilamide—CYP3A4—Trimethadione—epilepsy syndrome	0.00366	0.00551	CbGbCtD
Sulfanilamide—CYP3A4—Felbamate—epilepsy syndrome	0.00366	0.00551	CbGbCtD
Sulfanilamide—CA6—ear—epilepsy syndrome	0.00363	0.246	CbGeAlD
Sulfanilamide—CYP2C9—Propofol—epilepsy syndrome	0.00356	0.00536	CbGbCtD
Sulfanilamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00344	0.00518	CbGbCtD
Sulfanilamide—CYP2C9—Phenobarbital—epilepsy syndrome	0.0034	0.00512	CbGbCtD
Sulfanilamide—CYP2D6—Propofol—epilepsy syndrome	0.00325	0.0049	CbGbCtD
Sulfanilamide—CYP2C9—Diazepam—epilepsy syndrome	0.00322	0.00485	CbGbCtD
Sulfanilamide—CYP3A4—Clonazepam—epilepsy syndrome	0.00311	0.00469	CbGbCtD
Sulfanilamide—CYP2C19—Valproic Acid—epilepsy syndrome	0.00306	0.0046	CbGbCtD
Sulfanilamide—CYP3A4—Clobazam—epilepsy syndrome	0.00298	0.00449	CbGbCtD
Sulfanilamide—CYP2C19—Topiramate—epilepsy syndrome	0.00276	0.00415	CbGbCtD
Sulfanilamide—CYP2C9—Valproic Acid—epilepsy syndrome	0.00254	0.00383	CbGbCtD
Sulfanilamide—CYP3A4—Rufinamide—epilepsy syndrome	0.00254	0.00382	CbGbCtD
Sulfanilamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00247	0.00372	CbGbCtD
Sulfanilamide—CYP3A4—Primidone—epilepsy syndrome	0.00231	0.00348	CbGbCtD
Sulfanilamide—CYP3A4—Phenytoin—epilepsy syndrome	0.00222	0.00334	CbGbCtD
Sulfanilamide—CYP3A4—Propofol—epilepsy syndrome	0.00207	0.00311	CbGbCtD
Sulfanilamide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00198	0.00298	CbGbCtD
Sulfanilamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00198	0.00298	CbGbCtD
Sulfanilamide—CYP3A4—Midazolam—epilepsy syndrome	0.00195	0.00293	CbGbCtD
Sulfanilamide—CYP3A4—Diazepam—epilepsy syndrome	0.00187	0.00282	CbGbCtD
Sulfanilamide—CYP3A4—Zonisamide—epilepsy syndrome	0.00183	0.00275	CbGbCtD
Sulfanilamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.00148	0.00222	CbGbCtD
Sulfanilamide—CYP3A4—Topiramate—epilepsy syndrome	0.00133	0.00201	CbGbCtD
Sulfanilamide—CA7—midbrain—epilepsy syndrome	0.000646	0.0438	CbGeAlD
Sulfanilamide—CA12—forebrain—epilepsy syndrome	0.000635	0.0431	CbGeAlD
Sulfanilamide—CA2—hindbrain—epilepsy syndrome	0.00059	0.04	CbGeAlD
Sulfanilamide—CA12—telencephalon—epilepsy syndrome	0.000584	0.0396	CbGeAlD
Sulfanilamide—Benzocaine—SCN8A—epilepsy syndrome	0.000583	0.165	CrCbGaD
Sulfanilamide—CA6—head—epilepsy syndrome	0.000542	0.0368	CbGeAlD
Sulfanilamide—CA7—cerebellum—epilepsy syndrome	0.0005	0.0339	CbGeAlD
Sulfanilamide—Benzocaine—SCN9A—epilepsy syndrome	0.000472	0.134	CrCbGaD
Sulfanilamide—Benzocaine—SCN3A—epilepsy syndrome	0.000451	0.128	CrCbGaD
Sulfanilamide—CA9—cerebellum—epilepsy syndrome	0.000439	0.0297	CbGeAlD
Sulfanilamide—Benzocaine—SCN4A—epilepsy syndrome	0.000434	0.123	CrCbGaD
Sulfanilamide—CA7—brain—epilepsy syndrome	0.000406	0.0275	CbGeAlD
Sulfanilamide—CYP2D6—hindbrain—epilepsy syndrome	0.000374	0.0254	CbGeAlD
Sulfanilamide—CA12—head—epilepsy syndrome	0.000364	0.0247	CbGeAlD
Sulfanilamide—CA12—nervous system—epilepsy syndrome	0.000345	0.0234	CbGeAlD
Sulfanilamide—CA2—brainstem—epilepsy syndrome	0.000338	0.0229	CbGeAlD
Sulfanilamide—CA12—central nervous system—epilepsy syndrome	0.000332	0.0225	CbGeAlD
Sulfanilamide—CA2—forebrain—epilepsy syndrome	0.000326	0.0221	CbGeAlD
Sulfanilamide—Benzocaine—SCN1A—epilepsy syndrome	0.000317	0.0897	CrCbGaD
Sulfanilamide—CA2—telencephalon—epilepsy syndrome	0.0003	0.0203	CbGeAlD
Sulfanilamide—Benzocaine—SCN2A—epilepsy syndrome	0.000279	0.0791	CrCbGaD
Sulfanilamide—CA12—brain—epilepsy syndrome	0.000264	0.0179	CbGeAlD
Sulfanilamide—Aminohippurate—SLCO1A2—epilepsy syndrome	0.00025	0.0709	CrCbGaD
Sulfanilamide—CYP2E1—telencephalon—epilepsy syndrome	0.000241	0.0163	CbGeAlD
Sulfanilamide—CA2—medulla oblongata—epilepsy syndrome	0.000236	0.016	CbGeAlD
Sulfanilamide—CA2—midbrain—epilepsy syndrome	0.000215	0.0146	CbGeAlD
Sulfanilamide—CYP2D6—brainstem—epilepsy syndrome	0.000215	0.0145	CbGeAlD
Sulfanilamide—CA2—spinal cord—epilepsy syndrome	0.00021	0.0142	CbGeAlD
Sulfanilamide—CYP2D6—forebrain—epilepsy syndrome	0.000207	0.014	CbGeAlD
Sulfanilamide—CYP2D6—telencephalon—epilepsy syndrome	0.00019	0.0129	CbGeAlD
Sulfanilamide—CYP2E1—medulla oblongata—epilepsy syndrome	0.000189	0.0128	CbGeAlD
Sulfanilamide—CA2—head—epilepsy syndrome	0.000187	0.0127	CbGeAlD
Sulfanilamide—CA2—nervous system—epilepsy syndrome	0.000177	0.012	CbGeAlD
Sulfanilamide—CA2—central nervous system—epilepsy syndrome	0.00017	0.0116	CbGeAlD
Sulfanilamide—CYP2E1—spinal cord—epilepsy syndrome	0.000169	0.0114	CbGeAlD
Sulfanilamide—CA2—cerebellum—epilepsy syndrome	0.000167	0.0113	CbGeAlD
Sulfanilamide—CYP2E1—head—epilepsy syndrome	0.00015	0.0102	CbGeAlD
Sulfanilamide—CYP2E1—nervous system—epilepsy syndrome	0.000142	0.00962	CbGeAlD
Sulfanilamide—CYP2E1—central nervous system—epilepsy syndrome	0.000137	0.00927	CbGeAlD
Sulfanilamide—CA2—brain—epilepsy syndrome	0.000135	0.00917	CbGeAlD
Sulfanilamide—CYP2E1—cerebellum—epilepsy syndrome	0.000134	0.00906	CbGeAlD
Sulfanilamide—Aminohippurate—ABCC2—epilepsy syndrome	0.00012	0.0339	CrCbGaD
Sulfanilamide—CYP2D6—head—epilepsy syndrome	0.000119	0.00804	CbGeAlD
Sulfanilamide—CYP3A4—nervous system—epilepsy syndrome	0.000114	0.00774	CbGeAlD
Sulfanilamide—CYP2D6—nervous system—epilepsy syndrome	0.000112	0.00762	CbGeAlD
Sulfanilamide—Sulfamethazine—ALB—epilepsy syndrome	0.00011	0.0312	CrCbGaD
Sulfanilamide—CYP3A4—central nervous system—epilepsy syndrome	0.00011	0.00746	CbGeAlD
Sulfanilamide—CYP2E1—brain—epilepsy syndrome	0.000109	0.00736	CbGeAlD
Sulfanilamide—CYP2D6—central nervous system—epilepsy syndrome	0.000108	0.00734	CbGeAlD
Sulfanilamide—Sulfamerazine—ALB—epilepsy syndrome	0.000108	0.0305	CrCbGaD
Sulfanilamide—CYP2D6—cerebellum—epilepsy syndrome	0.000106	0.00717	CbGeAlD
Sulfanilamide—CYP2D6—brain—epilepsy syndrome	8.59e-05	0.00582	CbGeAlD
Sulfanilamide—Sulfamethizole—ALB—epilepsy syndrome	8.36e-05	0.0237	CrCbGaD
Sulfanilamide—Sulfaphenazole—CYP2D6—epilepsy syndrome	7.41e-05	0.021	CrCbGaD
Sulfanilamide—Dapsone—CYP2C19—epilepsy syndrome	6.62e-05	0.0187	CrCbGaD
Sulfanilamide—Benzocaine—ABCB1—epilepsy syndrome	5.27e-05	0.0149	CrCbGaD
Sulfanilamide—Sulfamethoxazole—ALB—epilepsy syndrome	4.69e-05	0.0133	CrCbGaD
Sulfanilamide—Aminohippurate—ABCB1—epilepsy syndrome	4.41e-05	0.0125	CrCbGaD
Sulfanilamide—Dapsone—PTGS2—epilepsy syndrome	4.12e-05	0.0117	CrCbGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	9.88e-06	0.000138	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—COX3—epilepsy syndrome	9.87e-06	0.000138	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—ALB—epilepsy syndrome	9.83e-06	0.000137	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—AGT—epilepsy syndrome	9.8e-06	0.000137	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—COX3—epilepsy syndrome	9.79e-06	0.000137	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—APOE—epilepsy syndrome	9.6e-06	0.000134	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ALDH7A1—epilepsy syndrome	9.53e-06	0.000133	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CACNA1A—epilepsy syndrome	9.53e-06	0.000133	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—GPX1—epilepsy syndrome	9.42e-06	0.000132	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	9.36e-06	0.000131	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	9.36e-06	0.000131	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	9.36e-06	0.000131	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PFKL—epilepsy syndrome	9.36e-06	0.000131	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	9.36e-06	0.000131	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ST3GAL3—epilepsy syndrome	9.33e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—UPB1—epilepsy syndrome	9.31e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NEU1—epilepsy syndrome	9.31e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ATIC—epilepsy syndrome	9.31e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—PTGS2—epilepsy syndrome	9.29e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	9.28e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	9.28e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	9.28e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PFKL—epilepsy syndrome	9.28e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	9.28e-06	0.00013	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ADSL—epilepsy syndrome	9.14e-06	0.000128	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	9.07e-06	0.000127	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	9.01e-06	0.000126	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GLUL—epilepsy syndrome	8.96e-06	0.000125	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	8.96e-06	0.000125	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CACNA1D—epilepsy syndrome	8.8e-06	0.000123	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GBE1—epilepsy syndrome	8.65e-06	0.000121	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	8.65e-06	0.000121	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—PTGS2—epilepsy syndrome	8.6e-06	0.00012	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—UPB1—epilepsy syndrome	8.56e-06	0.00012	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NEU1—epilepsy syndrome	8.56e-06	0.00012	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ATIC—epilepsy syndrome	8.56e-06	0.00012	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ATIC—epilepsy syndrome	8.48e-06	0.000119	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—UPB1—epilepsy syndrome	8.48e-06	0.000119	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NEU1—epilepsy syndrome	8.48e-06	0.000119	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.46e-06	0.000118	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—AGT—epilepsy syndrome	8.26e-06	0.000115	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—POMC—epilepsy syndrome	8.25e-06	0.000115	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	8.24e-06	0.000115	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—TXNRD1—epilepsy syndrome	8.23e-06	0.000115	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	8.17e-06	0.000114	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	8.13e-06	0.000114	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—APOE—epilepsy syndrome	8.09e-06	0.000113	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	8.07e-06	0.000113	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ADK—epilepsy syndrome	8.07e-06	0.000113	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	8.07e-06	0.000113	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	8.07e-06	0.000113	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	8.07e-06	0.000113	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	8.07e-06	0.000113	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—AQP1—epilepsy syndrome	7.99e-06	0.000112	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	7.96e-06	0.000111	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GBE1—epilepsy syndrome	7.96e-06	0.000111	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	7.91e-06	0.000111	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GBE1—epilepsy syndrome	7.89e-06	0.00011	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	7.89e-06	0.00011	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NT5E—epilepsy syndrome	7.71e-06	0.000108	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ALAD—epilepsy syndrome	7.71e-06	0.000108	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	7.71e-06	0.000108	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—ALB—epilepsy syndrome	7.52e-06	0.000105	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	7.48e-06	0.000105	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	7.42e-06	0.000104	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	7.38e-06	0.000103	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	7.38e-06	0.000103	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	7.38e-06	0.000103	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	7.38e-06	0.000103	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	7.36e-06	0.000103	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	7.36e-06	0.000103	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	7.28e-06	0.000102	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—KCNJ11—epilepsy syndrome	7.23e-06	0.000101	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CHRM3—epilepsy syndrome	7.23e-06	0.000101	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	7.21e-06	0.000101	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	7.2e-06	0.000101	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NT5E—epilepsy syndrome	7.09e-06	9.91e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ALAD—epilepsy syndrome	7.09e-06	9.91e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ADSL—epilepsy syndrome	7.05e-06	9.85e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NT5E—epilepsy syndrome	7.03e-06	9.82e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ALAD—epilepsy syndrome	7.03e-06	9.82e-05	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—POMC—epilepsy syndrome	6.95e-06	9.71e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GLUL—epilepsy syndrome	6.92e-06	9.66e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CA4—epilepsy syndrome	6.86e-06	9.59e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	6.86e-06	9.59e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	6.84e-06	9.56e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	6.79e-06	9.48e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	6.77e-06	9.45e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	6.77e-06	9.45e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	6.71e-06	9.37e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	6.71e-06	9.37e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	6.62e-06	9.25e-05	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—PTGS2—epilepsy syndrome	6.58e-06	9.19e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	6.56e-06	9.17e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ADSL—epilepsy syndrome	6.49e-06	9.06e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.45e-06	9.02e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	6.43e-06	8.98e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.36e-06	8.89e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	6.35e-06	8.87e-05	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—ALB—epilepsy syndrome	6.34e-06	8.85e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	6.31e-06	8.81e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.24e-06	8.72e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	6.19e-06	8.65e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—AQP1—epilepsy syndrome	6.16e-06	8.61e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.12e-06	8.55e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.12e-06	8.55e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.12e-06	8.55e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.12e-06	8.55e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.12e-06	8.55e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.92e-06	8.27e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	5.89e-06	8.23e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.84e-06	8.16e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	5.79e-06	8.09e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	5.74e-06	8.02e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	5.7e-06	7.97e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.67e-06	7.92e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.62e-06	7.85e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.6e-06	7.82e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.6e-06	7.82e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.6e-06	7.82e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.57e-06	7.79e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.57e-06	7.79e-05	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—PTGS2—epilepsy syndrome	5.54e-06	7.75e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.4e-06	7.54e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.39e-06	7.53e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.2e-06	7.27e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.2e-06	7.27e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.19e-06	7.25e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	5.15e-06	7.19e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.13e-06	7.16e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.13e-06	7.16e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.09e-06	7.11e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.08e-06	7.1e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.08e-06	7.1e-05	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—AKT1—epilepsy syndrome	5e-06	6.99e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	4.9e-06	6.85e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.89e-06	6.83e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—BCHE—epilepsy syndrome	4.88e-06	6.82e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.76e-06	6.65e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.73e-06	6.61e-05	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—AKT1—epilepsy syndrome	4.67e-06	6.52e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	4.66e-06	6.51e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.64e-06	6.48e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.64e-06	6.48e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.64e-06	6.48e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	4.61e-06	6.43e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—TH—epilepsy syndrome	4.59e-06	6.41e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.54e-06	6.35e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.42e-06	6.18e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.42e-06	6.18e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.4e-06	6.15e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.37e-06	6.11e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.33e-06	6.05e-05	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—AKT1—epilepsy syndrome	4.32e-06	6.04e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.24e-06	5.93e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.18e-06	5.84e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.16e-06	5.81e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.14e-06	5.79e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.08e-06	5.7e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.07e-06	5.69e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.05e-06	5.66e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.04e-06	5.64e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.01e-06	5.61e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.98e-06	5.57e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.98e-06	5.57e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.97e-06	5.55e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	3.83e-06	5.35e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.82e-06	5.33e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.78e-06	5.28e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CAT—epilepsy syndrome	3.78e-06	5.28e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.77e-06	5.26e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.71e-06	5.18e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	3.68e-06	5.14e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.63e-06	5.08e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.62e-06	5.06e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.59e-06	5.02e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.55e-06	4.96e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—TH—epilepsy syndrome	3.54e-06	4.95e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.49e-06	4.87e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.48e-06	4.86e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.46e-06	4.84e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.45e-06	4.82e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.43e-06	4.8e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GPX1—epilepsy syndrome	3.42e-06	4.77e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.35e-06	4.68e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.35e-06	4.68e-05	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—AKT1—epilepsy syndrome	3.31e-06	4.62e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.3e-06	4.62e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.28e-06	4.58e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.27e-06	4.57e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—TH—epilepsy syndrome	3.26e-06	4.55e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.24e-06	4.53e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—TH—epilepsy syndrome	3.23e-06	4.51e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.18e-06	4.44e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—AGT—epilepsy syndrome	3e-06	4.19e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.95e-06	4.13e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—APOE—epilepsy syndrome	2.94e-06	4.1e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.92e-06	4.07e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.84e-06	3.96e-05	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—AKT1—epilepsy syndrome	2.79e-06	3.89e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.73e-06	3.82e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.72e-06	3.8e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.69e-06	3.76e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.68e-06	3.75e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.66e-06	3.72e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.66e-06	3.71e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.65e-06	3.7e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.64e-06	3.68e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.61e-06	3.64e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.59e-06	3.61e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—POMC—epilepsy syndrome	2.52e-06	3.52e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.43e-06	3.39e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.4e-06	3.36e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.39e-06	3.34e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.31e-06	3.23e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ALB—epilepsy syndrome	2.3e-06	3.21e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.27e-06	3.18e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.27e-06	3.17e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.26e-06	3.16e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.16e-06	3.02e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.14e-06	2.99e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—TH—epilepsy syndrome	2.13e-06	2.97e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.13e-06	2.97e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.11e-06	2.95e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.08e-06	2.91e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.07e-06	2.89e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	2.01e-06	2.81e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.95e-06	2.72e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.79e-06	2.5e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.78e-06	2.48e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.77e-06	2.48e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.77e-06	2.48e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.75e-06	2.45e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.71e-06	2.38e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.63e-06	2.28e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.62e-06	2.26e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.59e-06	2.22e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.55e-06	2.17e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.43e-06	1.99e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.42e-06	1.98e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.39e-06	1.94e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.36e-06	1.9e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.17e-06	1.64e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.07e-06	1.49e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—AKT1—epilepsy syndrome	1.01e-06	1.41e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.33e-07	1.3e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	7.8e-07	1.09e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.18e-07	1e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	7.11e-07	9.94e-06	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.69e-07	6.55e-06	CbGpPWpGaD
